Compositions and method for optimized peptide vaccines using residue optimization | Patent Number 11672850

US 11672850 B2
Application Number17729290
Publication NumberUS 20220370584 A1
Pendency1 year, 1 month, 18 days
Filled DateApr 26, 2022
Priority DateApr 28, 2021
Publication DateNov 24, 2022
Expiration DateApr 27, 2041
Inventor/ApplicantsBrandon CARTER
David Kenneth GIFFORD
Brandon Carter
David Kenneth Gifford
ExaminesD' AMBROSIO, THEA
Art Unit1654
Technology Center1600
Assignments
Think Therapeutics Inc.
Current
Think Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.